Concordance between homeostatic model assessment and triglyceride glucose index in assessing insulin resistance among HIV-infected patients

References

1. 1.↵
   1. Yoshikura H

   . Age distribution of people dying of HIV/AIDS that shifted toward older ages by 10 years in the past 20 odd years. Jpn J Infect Dis 2019; 72: 31-37.

   OpenUrlPubMed
2. 2.↵
   1. Wandeler G,
   2. Johnson LF,
   3. Egger M

   . Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general population. Curr Opin HIV AIDS 2016; 11: 492-500.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Husain NE,
   2. Noor SK,
   3. Elmadhoun WM,
   4. Almobarak AO,
   5. Awadalla H,
   6. Woodward CL, et al.

   Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten. HIV AIDS (Auckl) 2017; 9: 193-202.

   OpenUrlPubMed
4. 4.↵
   1. Soulat-Dufour L,
   2. Lang S,
   3. Ederhy S,
   4. Ancedy Y,
   5. Beraud AS,
   6. Adavane-Scheuble S, et al.

   Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment. Expert Opin Drug Saf 2019; 18: 829-840.

   OpenUrlCrossRefPubMed
5. 5.
   1. Bailin SS,
   2. Gabriel CL,
   3. Wanjalla CN,
   4. Koethe JR

   . Obesity and weight gain in persons with HIV. Curr HIV/AIDS Rep 2020; 17: 138-150.

   OpenUrlCrossRef
6. 6.↵
   1. Lee SH,
   2. Park SY,
   3. Choi CS

   . Insulin resistance: From mechanisms to therapeutic strategies. Diabetes Metab J 2022; 46:15-37.

   OpenUrlPubMed
7. 7.↵
   1. Gast KB,
   2. Tjeerdema N,
   3. Stijnen T,
   4. Smit JWA,
   5. Dekkers OM

   . Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One 2012; 7: e52036.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Demir AK,
   2. Şahin Ş,
   3. Kaya SU,
   4. Bütün İ,
   5. Çıtıl R,
   6. Önder Y, et al.

   Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the middle Black Sea region of Turkey. Afr Health Sci 2020; 20: 277-286.

   OpenUrlPubMed
9. 9.↵
   1. Sánchez-García A,
   2. Rodríguez-Gutiérrez R,
   3. Mancillas-Adame L,
   4. González-Nava V,
   5. González-Colmenero AD,
   6. Solis RC, et al.

   Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: A systematic review. Int J Endocrinol 2020; 2020: 4678526.

   OpenUrlPubMed
10. 10.↵
    1. Lopez-Jaramillo P,
    2. Gomez-Arbelaez D,
    3. Martinez-Bello D,
    4. Abat MEM,
    5. Alhabib KF,
    6. Avezum Á, et al.

    Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev 2023; 4: e23–e33.

    OpenUrl
11. 11.↵
    1. Tiozzo E,
    2. Rodriguez A,
    3. Konefal J,
    4. Farkas GJ,
    5. Maher JL,
    6. Lewis JE

    . The Relationship between HIV Duration, Insulin Resistance and Diabetes Risk. Int J Environ Res Public Health 2021; 18: 3926.

    OpenUrlPubMed
12. 12.↵
    1. Nabipoorashrafi SA,
    2. Seyedi SA,
    3. Rabizadeh S,
    4. Ebrahimi M,
    5. Ranjbar SA,
    6. Reyhan SK, et al.

    The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2022; 32: 2677-2688.

    OpenUrlPubMed
13. 13.↵
    1. Park HM,
    2. Lee HS,
    3. Lee YJ,
    4. Lee JH

    . The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract 2021; 180: 109042.

    OpenUrlPubMed
14. 14.↵
    1. Gayoso-Diz P,
    2. Otero-González A,
    3. Rodriguez-Alvarez MX,
    4. Gude F,
    5. García F,
    6. De Francisco A, et al.

    Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 2013; 13: 1-10.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Do HD,
    2. Lohsoosthorn V,
    3. Jiamjarasrangsi W,
    4. Lertmaharit S,
    5. Williams MA

    . Prevalence of insulin resistance and its relationship with cardiovascular disease risk factors among Thai adults over 35 years old. Diabetes Res Clin Pract 2010; 89: 303-308.

    OpenUrlPubMed
16. 16.↵
    1. Gastaldelli A

    . Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring) 2022; 30: 1549-1563.

    OpenUrlPubMed
17. 17.↵
    1. Kang B,
    2. Yang Y,
    3. Lee EY,
    4. Yang HK,
    5. Kim HS,
    6. Lim SY, et al.

    Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes (Lond) 2017; 41: 789-792.

    OpenUrlPubMed
18. 18.↵
    1. Yaribeygi H,
    2. Farrokhi FR,
    3. Butler AE,
    4. Sahebkar A

    . Insulin resistance: Review of the underlying molecular mechanisms. J Cell Physiol 2019; 234: 8152-8161.

    OpenUrlCrossRefPubMed
19. 19.
    1. Nguyen KA,
    2. Peer N,
    3. Mills EJ,
    4. Kengne AP

    . A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population. PLoS One 2016; 11: e0150970.

    OpenUrlPubMed
20. 20.↵
    1. Schulte-Hermann K,
    2. Schalk H,
    3. Haider B,
    4. Hutterer J,
    5. Gmeinhart B,
    6. Pichler K, et al.

    Impaired lipid profile and insulin resistance in a cohort of Austrian HIV patients. Infect Chemother 2016; 22: 248–253.

    OpenUrl
21. 21.↵
    1. Tian X,
    2. Zuo Y,
    3. Chen S,
    4. Liu Q,
    5. Tao B,
    6. Wu S, et al.

    Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort. Cardiovasc Diabetol 2021; 20: 1-10.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Lewden C,
    2. Bouteloup V,
    3. De Wit S,
    4. Sabin C,
    5. Mocroft A,
    6. Wasmuth JC, et al.

    All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2011; 41: 433-445.

    OpenUrlPubMed
23. 23.↵
    1. Dominick L,
    2. Midgley N,
    3. Swart LM,
    4. Sprake D,
    5. Deshpande G,
    6. Laher I, et al.

    HIV-related cardiovascular diseases: the search for a unifying hypothesis. Am J Physiol Heart Circ Physiol 2020; 318: H731-H746.

    OpenUrlPubMed
24. 24.↵
    1. Hong S,
    2. Han K,
    3. Park CY

    . The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med 2020; 18: 1-8.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Watanabe Y,
    2. Nagai Y,
    3. Takatsu K

    . Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance. Nutrients 2013; 5: 3757-3778.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Willig AL,
    2. Overton ET

    . Metabolic complications and glucose metabolism in HIV infection: A review of the evidence. Curr HIV/AIDS Rep 2016; 13: 289-296.

    OpenUrlCrossRef
27. 27.↵
    1. Masenga SK,
    2. Elijovich F,
    3. Koethe JR,
    4. Hamooya BM,
    5. Heimburger DC,
    6. Munsaka SM, et al.

    Hypertensionandmetabolicsyndrome in persons with HIV. Curr Hypertens Rep 2020; 22: 1-8.

    OpenUrlPubMed
28. 28.↵
    1. Mu W,
    2. Patankar V,
    3. Kitchen S,
    4. Zhen A

    . Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV Infection. Viruses 2024; 16: 219.

    OpenUrlPubMed
29. 29.↵
    1. Mohan J,
    2. Ghazi T,
    3. Chuturgoon AA

    . A critical review of the biochemical mechanisms and epigenetic modifications in HIV-and antiretroviral-induced metabolic syndrome. Int J Mol Sci 2021; 22: 12020.

    OpenUrlPubMed